Skip to content
MarketScale
‹ Back to IndustriesHealthcare

It’ll Take a Village to Deliver the Innovative, Less Invasive, Affordable Solutions to the Healthcare Market with Raja Abid

There’s no getting around the fact that the healthcare industry needs solutions to help solve its myriad challenges. A holistic approach to healthcare solutions is a pathway Raja Abid, Healthcare Economic Leader at Boston Scientific, believes can deliver innovative, less invasive, and affordable solutions to the healthcare market. Abid kicked off his career in med…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

There’s no getting around the fact that the healthcare industry needs solutions to help solve its myriad challenges. A holistic approach to healthcare solutions is a pathway Raja Abid, Healthcare Economic Leader at Boston Scientific, believes can deliver innovative, less invasive, and affordable solutions to the healthcare market.

Abid kicked off his career in med school. He discovered there were so many facets to healthcare he wanted to learn different sides of the market. Abid got his MBA in healthcare administration, which opened his eyes to the many possibilities for him to make a difference. Keeping an open mind is a trait Abid values, and it’s what guided him through his career and led him to Boston Scientific.

All areas within healthcare offer tremendous value and opportunities to create solutions, but the siloing that often accompanies these areas must dissipate to allow for better communication. “The only way you’re going to improve quality, value, and delivery of care, is when everybody starts talking to each other, builds care pathways that make sense, efficient, and highly effective,” Abid said. Still, Abid believes the next ten years in healthcare will focus on solving this challenge.

In Abid’s role with Boston Scientific, he provides economic support data, so healthcare organizations understand the financial impact of the devices they purchase. A device may seem like a significant spend, but long-term financial benefits and positive patient results generated from that device could be tremendous.

Seeing healthcare from the side of a device manufacturer, Abid knows that solutions come from partnerships. “Medical device companies come up with new products and technologies. We educate the physicians and the patients on their options because, as you can imagine, most patients go to a physician, and a physician’s going to do what they’ve been doing for the last fifteen to twenty years.” Educating the healthcare community on the latest innovations can make all the difference.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512